Call for expert advice 202-780-4988
Developing a Drug? Leverage our Experience.
Without a well thought out preclinical IND strategy, you run the risk of spending more money and incurring more time executing the necessary requirements of the FDA.
We start by learning about your molecule and current formulation, building a program that starts from where your last assay & testing left off. Contact us for a gap analysis and initial advisory based on your situation.
We are experienced drug development professionals. We offer preclinical services and key insight necessary to take your drug development program to IND submission. DMPK, formulation, GLP toxicology, API synthesis and free initial consulting. Contact us for a free GAP ANALYSIS assessment today.
Advancing Drugs has brought over 30 drugs through IND submission. We can augment your knowledge and capabilities in any area of the drug development process.
We provide Individual preclinical CRO services or Fully Integrated preclinical service programs:
Drug Candidate Selected?
We work with you to get your drug into the clinic
Our experience will help you anticipate problems before they occur
The Advancing Drugs provides preclinical CRO services and has a highly experience staff of drug development experts specializing in the all areas of preclinical service required for FDA IND (Investigation New Drug) submission. Collectively, this expertise covers the drug development continuum from DMPK to candidate nomination to IND submission.